Table 2.
CDV | CPV-2 | CCoV | CRV | CAdV | |
---|---|---|---|---|---|
Single infection | 30/113 (26.5%) | 51/113 (45.1%) | 23/113 (20.3%) | 5/113 (4.4%) | 4/113 (3.5%) |
CDV + CPV-2 | 30/67 (44.7%) | 30/67 (44.7%) | |||
CPV-2 + CCoV | 10/67 (14.9%) | 10/67 (14.9%) | |||
CDV + CCoV | 9/67 (13.4%) | 9/67 (13.4%) | |||
CCoV + CRV | 4/67 (5.9%) | 4/67 (5.9%) | |||
CDV + CAdV | 2/67 (2.9%) | 2/67 (2.9%) | |||
CPV-2 + CRV | 1/67 (1.5%) | 1/67 (1.5%) | |||
CPV-2 + CAdV | 1/67 (1.5%) | 1/67 (1.5%) | |||
CCoV + CAdV | 1/67 (1.5%) | 1/67 (1.5%) | |||
CRV + CAdV | 0 | 0 | |||
CDV + CPV-2 + CCoV | 3/67 (4.4%) | 3/67 (4.4%) | 3/67 (4.4%) | ||
CDV + CCoV + CRV | 2/67 (2.9%) | 2/67 (2.9%) | 2/67 (2.9%) | ||
CDV + CPV-2 + CAdV | |||||
CDV + CPV-2 + CRV | 1/67 (1.5%) | 1/67 (1.5%) | 1/67 (1.5%) | ||
CDV + CCoV + CAdV | |||||
CPV-2 + CCoV + CAdV | |||||
CPV-2 + CCoV + CRV | 1/67 (1.5%) | 1/67 (1.5%) | 1/67 (1.5%) | ||
CCoV + CRV + CAdV | |||||
CDV + CPV-2 + CCoV + CRV | 1/67 (1.5%) | 1/67 (1.5%) | 1/67 (1.5%) | 1/67 (1.5%) | |
CDV + CPV-2 + CCoV + CAdV | 1/67 (1.5%) | 1/67 (1.5%) | 1/67 (1.5%) | 1/67 (1.5%) | |
Total | 83/184 | 100/184 | 23/184 | 15/184 | 9/184 |